Katrine Bosley, President and CEO at Editas Medicine, Inc. (EDIT), sold 24,000 shares at $31.44 ($745K) on 2018-10-01, disclosed to the SEC on 2018-10-03.
Open-market sale of $745k EDIT by President and CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $30.64 | 6,234 | $191K | 25.7% |
| 2 | $30.64 | 6,234 | $191K | 25.7% |
| 3 | $31.44 | 5,766 | $181K | 24.3% |
| 4 | $31.44 | 5,766 | $181K | 24.3% |
| Total | $31.02 avg | 24,000 | $745K | 100% |
| Filing → |
| EDIT | SELL | 2018-11-05 | $323K | — | Filing → |
| EDIT | SELL | 2018-09-06 | $736K | — | Filing → |
| EDIT | SELL | 2018-08-22 | $724K | — | Filing → |